Leading cancer researchers from UC San Francisco presented talks about advances in targeted therapies, cancer genomics, using AI to personalize cancer treatment, improving diagnosis of hard-to-treat ...

May 5, 2025 /PRNewswire/ -- (Family Features) Strokes can happen to anyone ... US FDA for a First-in-Human Clinical Trial of an mRNA destabilizing drug targeting c-MYC driven cancers UTR Therapeutics ...

Dental Care Alliance (DCA), one of the nation's leading dental support organizations, proudly celebrated its top-performing providers during the inaugural President's Club event, held April 26, 2025, ...

Deregulated expression of MYC family transcription factors is present in more than 70% of human cancers. MYC is an intrinsically disordered protein without known drug binding pockets and is essential ...

Human α–lactalbumin made lethal to tumor cells (HAMLET) is the first member in a new family of protein–lipid ... expression including Ras and c-Myc and by glycolytic enzymes.

Amplification of each member of the MYC family of oncogenes (MYCN, CMYC, MYCL) has been found in MB tumors and amplified-MYCN or CMYC correlates with poor prognosis. Since transcription factors such ...

The prototype of this family, TGF-ß1, is expressed by all hematopoietic cell ... specifically rearrangements of the c-myc gene, that are characteristic of human lymphomas. We provided the first ...

MYC is dysregulated in nearly 70% of human cancers, where it influences a vast network of biological processes including cell cycle control, metabolism, apoptosis, angiogenesis, and immune evasion.